TCTAP A-129 An Indian Overview of the “TRA–PCI in STEMI” Conundrum: Is Radial STEMI Ready for Prime Time?

[...]multiple factors, including more aggressive antithrombotic and antiplatelet therapies, lead to a higher risk - adjusted rate of mainly access -site related hemorrhagic complications in these patients, especially when femoral route is used, leading to worse clinical outcomes. Radial route was de...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 63; no. 12; p. S37
Main Authors Bali, Harinder K, Chattree, Kapil K, Chauhan, Hiteshi K.C
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.04.2014
Elsevier Limited
Subjects
Cardiology
Cardiovascular
Catheters
Drug therapy
Heart attacks
Internal Medicine
Mortality
Patients
Stroke
Online AccessGet full text

Cover

More Information
Summary:[...]multiple factors, including more aggressive antithrombotic and antiplatelet therapies, lead to a higher risk - adjusted rate of mainly access -site related hemorrhagic complications in these patients, especially when femoral route is used, leading to worse clinical outcomes. Radial route was default one; femoral route used only in 26 patients due to cardiogenic shock requiring IABP, post-CABG status and access site crossover. Conclusion TRA in STEMI, even taking in account the 'Radial paradox' and other confounders, lowers morbidity and cardiac mortality primarily due to reduction in vascular access site-related hemorrhagic events.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.02.157